SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001600132-19-000063
Filing Date
2019-03-28
Accepted
2019-03-28 08:30:00
Documents
3
Effectiveness Date
2019-03-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A blphproxyamarch2019.htm DEFA14A 12127
2 a03104cbellerophontherap01.jpg GRAPHIC 321858
3 a03104cbellerophontherapeuti.jpg GRAPHIC 849316
  Complete submission text file 0001600132-19-000063.txt   1626556
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36845 | Film No.: 19710035
SIC: 2834 Pharmaceutical Preparations